This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Li, C. J. Articles by Pardee, A. B. Search for Related Content PubMed PubMed Citation Articles by Li, C. J. Articles by Pardee, A. B.

Induction of Apoptosis by ß-Lapachone in Human Prostate Cancer Cells¹

Division of Cell Growth and Regulation, Dana-Farber Cancer Institute, and Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115

ß-Lapachone, a plant product, has been shown to be a novel inhibitor of DNA topoisomerase I, with a mode of action different from camptothecin and a chemical structure distinct from those of current anti-cancer drugs. We observed that ß-lapachone, at concentrations of less than 8 µM, induces cell death with characteristics of apoptosis in human prostate cancer cell lines. This effect of ß-lapachone was also observed in a human promyelocytic leukemia cell line (HL-60). ß-Lapachone-induced apoptosis is independent of p53 expression, and ectopic overexpression of bcl-2 did not confer significant resistance to ß-lapachone. Among other human carcinoma and adenoma cell lines tested, human breast and ovary carcinoma showed sensitivity to the cytotoxic effect of ß-lapachone without manifesting signs of apoptosis. These results suggest that ß-lapachone is a potential compound to be added to cancer chemotherapy, particularly for prostate cancer.

¹ This work was supported by NIH Grant AI-35511.

² To whom requests for reprints should be addressed, at Division of Cell Growth and Regulation, Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA 02115.

Received 6/14/95. Accepted 7/21/95.

This article has been cited by other articles:

				H. J. Park, E. K. Choi, J. Choi, K.-J. Ahn, E. J. Kim, I.-M. Ji, Y. H. Kook, S.-D. Ahn, B. Williams, R. Griffin, et al. Heat-Induced Up-Regulation of NAD(P)H:Quinone Oxidoreductase Potentiates Anticancer Effects of {beta}-Lapachone Clin. Cancer Res., December 15, 2005; 11(24): 8866 - 8871. [Abstract] [Full Text] [PDF]

				J. A. Olalde Rangel, M. Magarici, F. Amendola, and O. del Castillo The Systemic Theory of Living Systems. Part IV: Systemic Medicine--The Praxis Evid. Based Complement. Altern. Med., December 1, 2005; 2(4): 429 - 439. [Abstract] [Full Text] [PDF]

				A. B. Pardee Regulation, Restriction, and Reminiscences J. Biol. Chem., July 19, 2002; 277(30): 26709 - 26716. [Full Text] [PDF]

				M.-J. Don, Y.-H. Chang, K.-K. Chen, L.-K. Ho, and Y.-P. Chau Induction of CDK Inhibitors (p21WAF1 and p27Kip1) and Bak in the {beta}-Lapachone-Induced Apoptosis of Human Prostate Cancer Cells Mol. Pharmacol., April 1, 2001; 59(4): 784 - 794. [Abstract] [Full Text]

				D. R.A. Mans, A. B. da Rocha, and G. Schwartsmann Anti-Cancer Drug Discovery and Development in Brazil: Targeted Plant Collection as a Rational Strategy to Acquire Candidate Anti-Cancer Compounds Oncologist, June 1, 2000; 5(3): 185 - 198. [Abstract] [Full Text]

				C. J. Li, Y.-Z. Li, A. V. Pinto, and A. B. Pardee Potent inhibition of tumor survival in vivo by beta -lapachone plus taxol: Combining drugs imposes different artificial checkpoints PNAS, November 9, 1999; 96(23): 13369 - 13374. [Abstract] [Full Text] [PDF]

				S.-G. Shiah, S.-E. Chuang, Y.-P. Chau, S.-C. Shen, and M.-L. Kuo Activation of c-Jun NH2-terminal Kinase and Subsequent CPP32/Yama during Topoisomerase Inhibitor {beta}-Lapachone-induced Apoptosis through an Oxidation-dependent Pathway Cancer Res., January 1, 1999; 59(2): 391 - 398. [Abstract] [Full Text] [PDF]

				M. J. Campbell, S. Park, M. R. Uskokovic, M. I. Dawson, and H. P. Koeffler Expression of Retinoic Acid Receptor-{beta} Sensitizes Prostate Cancer Cells to Growth Inhibition Mediated by Combinations of Retinoids and a 19-nor Hexafluoride Vitamin D3 Analog Endocrinology, April 1, 1998; 139(4): 1972 - 1980. [Abstract] [Full Text] [PDF]

				C. Tagliarino, J. J. Pink, G. R. Dubyak, A.-L. Nieminen, and D. A. Boothman Calcium Is a Key Signaling Molecule in beta -Lapachone-mediated Cell Death J. Biol. Chem., May 25, 2001; 276(22): 19150 - 19159. [Abstract] [Full Text] [PDF]